Biblio

Export 644 results:
Author Title Type [ Year(Desc)]
Filters: First Letter Of Last Name is J  [Clear All Filters]
2017
A. R. Morgan, Touchard, S., O'Hagan, C., Sims, R., Majounie, E., Escott-Price, V., Jones, L., Williams, J., and B Morgan, P., “The Correlation between Inflammatory Biomarkers and Polygenic Risk Score in Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 1, pp. 25-36, 2017.
A. Pink, Przybelski, S. A., Krell-Roesch, J., Stokin, G. B., Roberts, R. O., Mielke, M. M., Knopman, D. S., Jack, C. R., Petersen, R. C., and Geda, Y. E., “Cortical Thickness and Depressive Symptoms in Cognitively Normal Individuals: The Mayo Clinic Study of Aging.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1273-1281, 2017.
I. Jurjević, Miyajima, M., Ogino, I., Akiba, C., Nakajima, M., Kondo, A., Kikkawa, M., Kanai, M., Hattori, N., and Arai, H., “Decreased Expression of hsa-miR-4274 in Cerebrospinal Fluid of Normal Pressure Hydrocephalus Mimics with Parkinsonian Syndromes.”, J Alzheimers Dis, vol. 56, no. 1, pp. 317-325, 2017.
M. Tuwaig, Savard, M., Jutras, B., Poirier, J., D Collins, L., Rosa-Neto, P., Fontaine, D., and Breitner, J. C. S., “Deficit in Central Auditory Processing as a Biomarker of Pre-Clinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1589-1600, 2017.
E. Jaul and Meiron, O., “Dementia and Pressure Ulcers: Is There a Close Pathophysiological Interrelation?”, J Alzheimers Dis, vol. 56, no. 3, pp. 861-866, 2017.
J. R. Gatchel, Donovan, N. J., Locascio, J. J., Schultz, A. P., J Becker, A., Chhatwal, J., Papp, K. V., Amariglio, R. E., Rentz, D. M., Blacker, D., Sperling, R. A., Johnson, K. A., and Marshall, G. A., “Depressive Symptoms and Tau Accumulation in the Inferior Temporal Lobe and Entorhinal Cortex in Cognitively Normal Older Adults: A Pilot Study.”, J Alzheimers Dis, vol. 59, no. 3, pp. 975-985, 2017.
B. Moon, Kim, S., Park, Y. Ho, Lim, J. - S., Youn, Y. Chul, Kim, S. Y., and Jang, J. - W., “Depressive Symptoms are Associated with Progression to Dementia in Patients with Amyloid-Positive Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1255-1264, 2017.
T. Fladby, Pålhaugen, L., Selnes, P., Waterloo, K., Bråthen, G., Hessen, E., Almdahl, I. Selseth, Arntzen, K. - A., Auning, E., Eliassen, C. Fredrik, Espenes, R., Grambaite, R., Grøntvedt, G. Rolfseng, Johansen, K. Kunszt, Johnsen, S. Harald, Kalheim, L. Flem, Kirsebom, B. - E., Müller, K. Ivar, Nakling, A. Exner, Rongve, A., Sando, S. Botne, Siafarikas, N., Stav, A. Løvli, Tecelao, S., Timon, S., Bekkelund, S. Ivar, and Aarsland, D., “Detecting At-Risk Alzheimer's Disease Cases.”, J Alzheimers Dis, vol. 60, no. 1, pp. 97-105, 2017.
T. Fladby, Pålhaugen, L., Selnes, P., Waterloo, K., Bråthen, G., Hessen, E., Almdahl, I. Selseth, Arntzen, K. - A., Auning, E., Eliassen, C. Fredrik, Espenes, R., Grambaite, R., Grøntvedt, G. Rolfseng, Johansen, K. Kunszt, Johnsen, S. Harald, Kalheim, L. Flem, Kirsebom, B. - E., Müller, K. Ivar, Nakling, A. Exner, Rongve, A., Sando, S. Botne, Siafarikas, N., Stav, A. Løvli, Tecelao, S., Timon, S., Bekkelund, S. Ivar, and Aarsland, D., “Detecting At-Risk Alzheimer's Disease Cases.”, J Alzheimers Dis, vol. 60, no. 1, pp. 97-105, 2017.
G. Richter Vaz, Hädrich, G., Bidone, J., Rodrigues, J. Lima, Falkembach, M. Corrêa, Putaux, J. - L., Hort, M. Appel, Monserrat, J. Maria, Junior, A. Sergio Var, Teixeira, H. Ferreira, Muccillo-Baisch, A. Luiza, Horn, A. Paula, and Dora, C. Lima, “Development of Nasal Lipid Nanocarriers Containing Curcumin for Brain Targeting.”, J Alzheimers Dis, vol. 59, no. 3, pp. 961-974, 2017.
W. J. Jansen, Handels, R. L. H., Visser, P. Jelle, Aalten, P., Bouwman, F., Claassen, J., van Domburg, P., Hoff, E., Hoogmoed, J., Leentjens, A. F. G., Rikkert, M. Olde, Oleksik, A. M., Smid, M., Scheltens, P., Wolfs, C., Verhey, F., and Ramakers, I. H. G. B., “The Diagnostic and Prognostic Value of Neuropsychological Assessment in Memory Clinic Patients.”, J Alzheimers Dis, vol. 55, no. 2, pp. 679-689, 2017.
L. Zhang, Sun, C., Jin, Y., Gao, K., Shi, X., Qiu, W., Ma, C., and Zhang, L., “Dickkopf 3 (Dkk3) Improves Amyloid-β Pathology, Cognitive Dysfunction, and Cerebral Glucose Metabolism in a Transgenic Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 2, pp. 733-746, 2017.
L. Yu, Wang, W., Pang, W., Xiao, Z., Jiang, Y., and Hong, Y., “Dietary Lycopene Supplementation Improves Cognitive Performances in Tau Transgenic Mice Expressing P301L Mutation via Inhibiting Oxidative Stress and Tau Hyperphosphorylation.”, J Alzheimers Dis, vol. 57, no. 2, pp. 475-482, 2017.
D. G. Amen, Darmal, B., Raji, C. A., Bao, W., Jorandby, L., Meysami, S., and Raghavendra, C. S., “Discriminative Properties of Hippocampal Hypoperfusion in Marijuana Users Compared to Healthy Controls: Implications for Marijuana Administration in Alzheimer's Dementia.”, J Alzheimers Dis, vol. 56, no. 1, pp. 261-273, 2017.
B. Xie, Liu, Z., Liu, W., Jiang, L., Zhang, R., Cui, D., Zhang, Q., and Xu, S., “DNA Methylation and Tag SNPs of the BDNF Gene in Conversion of Amnestic Mild Cognitive Impairment into Alzheimer's Disease: A Cross-Sectional Cohort Study.”, J Alzheimers Dis, vol. 58, no. 1, pp. 263-274, 2017.
S. Jiang and Bhaskar, K., “Dynamics of the Complement, Cytokine, and Chemokine Systems in the Regulation of Synaptic Function and Dysfunction Relevant to Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1123-1135, 2017.
T. Laiterä, Paananen, J., Helisalmi, S., Sarajärvi, T., Huovinen, J., Laitinen, M., Rauramaa, T., Alafuzoff, I., Remes, A. M., Soininen, H., Haapasalo, A., Jääskeläinen, J. E., Leinonen, V., and Hiltunen, M., “Effects of Alzheimer's Disease-Associated Risk Loci on Amyloid-β Accumulation in the Brain of Idiopathic Normal Pressure Hydrocephalus Patients.”, J Alzheimers Dis, vol. 55, no. 3, pp. 995-1003, 2017.
S. Craft, Claxton, A., Baker, L. D., Hanson, A. J., Cholerton, B., Trittschuh, E. H., Dahl, D., Caulder, E., Neth, B., Montine, T. J., Jung, Y., Maldjian, J., Whitlow, C., and Friedman, S., “Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1325-1334, 2017.
J. Jia, Wei, C., Jia, L., Tang, Y., Liang, J., Zhou, A., Li, F., Shi, L., and Doody, R. S., “Efficacy and Safety of Donepezil in Chinese Patients with Severe Alzheimer's Disease: A Randomized Controlled Trial.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1495-1504, 2017.
J. Jia, Wei, C., Jia, L., Tang, Y., Liang, J., Zhou, A., Li, F., Shi, L., and Doody, R. S., “Efficacy and Safety of Donepezil in Chinese Patients with Severe Alzheimer's Disease: A Randomized Controlled Trial.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1495-1504, 2017.
S. - M. Shim, Cheon, H. - S., Jo, C., Koh, Y. Ho, Song, J., and Jeon, J. - P., “Elevated Epstein-Barr Virus Antibody Level is Associated with Cognitive Decline in the Korean Elderly.”, J Alzheimers Dis, vol. 55, no. 1, pp. 293-301, 2017.
S. - M. Shim, Cheon, H. - S., Jo, C., Koh, Y. Ho, Song, J., and Jeon, J. - P., “Elevated Epstein-Barr Virus Antibody Level is Associated with Cognitive Decline in the Korean Elderly.”, J Alzheimers Dis, vol. 55, no. 1, pp. 293-301, 2017.
B. Xie, Xu, Y., Liu, Z., Liu, W., Jiang, L., Zhang, R., Cui, D., Zhang, Q., and Xu, S., “Elevation of Peripheral BDNF Promoter Methylation Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Longitudinal Study.”, J Alzheimers Dis, vol. 56, no. 1, pp. 391-401, 2017.
J. M. Jiang, Seng, E. K., Zimmerman, M. E., Sliwinski, M., Kim, M., and Lipton, R. B., “Evaluation of the Reliability, Validity, and Predictive Validity of the Subscales of the Perceived Stress Scale in Older Adults.”, J Alzheimers Dis, vol. 59, no. 3, pp. 987-996, 2017.
A. Polcher, Frommann, I., Koppara, A., Wolfsgruber, S., Jessen, F., and Wagner, M., “Face-Name Associative Recognition Deficits in Subjective Cognitive Decline and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1185-1196, 2017.

Pages